Single nucleotide polymorphisms in the multidrug resistance 1 gene in Korean epileptics
Authors:
- Myeong Kyu KimMKMyeong Kyu Kim
- Young Jong WooYWYoung Jong Woo
- Min Cheol LeeMLMin Cheol Lee
- Jin Hee KimJKJin Hee Kim
- Ki Won ParkKPKi Won Park
- Eun Young KimEKEun Young Kim
- Young Il RohYRYoung Il Roh
- Chan Jong KimCKChan Jong Kim
- 1 January 2006
- journal article
- research article
- Published by Elsevier in Seizure: European Journal of Epilepsy
- Vol. 15 (1) , 67-72
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Pharmacogenetics: potential for individualized drug therapy through geneticsTrends in Genetics, 2003
- Association of Multidrug Resistance in Epilepsy with a Polymorphism in the Drug-Transporter GeneABCB1New England Journal of Medicine, 2003
- Mechanisms of antiepileptic drug resistanceCurrent Opinion in Neurology, 2003
- MDR1 single nucleotide polymorphisms: multiplicity of haplotypes and functional consequencesPharmacogenetics, 2002
- P-Glycoprotein-mediated efflux of phenobarbital, lamotrigine, and felbamate at the blood–brain barrier: evidence from microdialysis experiments in ratsNeuroscience Letters, 2002
- Role of Multidrug Transporters in Pharmacoresistance to Antiepileptic DrugsThe Journal of Pharmacology and Experimental Therapeutics, 2002
- P-glycoprotein and multidrug resistance-associated protein are involved in the regulation of extracellular levels of the major antiepileptic drug carbamazepine in the brainNeuroReport, 2001
- In Vivo Evidence for P‐Glycoprotein–Mediated Transport of Phenytoin at the Blood–Brain Barrier of RatsEpilepsia, 2001
- Clinical aspects and biological bases of drug-resistant epilepsiesEpilepsy Research, 1999
- Is the underlying cause of epilepsy a major prognostic factor for recurrence?Neurology, 1998